Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (7733)	1/15/2003 12:29:40 PM
From: A.J. Mullen	Read Replies (1) \| Respond to of 52153

From my cursory and inexpert reading of the report Iceberg posted, it seems that that patient was killed by adenovirus itself, which he got in a massive quantity. In the French cases they've contracted cancer, which I assume was not the expected result of infection by the retrovirus. This seems another issue entirely. If the issue is where the payload ends up, then the moratorium should extend to all genetic therapy shouldn't it? I would think there is less control of where the DNA is inserted in naked DNA therapy than when using a virus - retro or otherwise. Ashley Ps. We have a friend in common. Annie S. in SD.